Amy L. Burroughs, CEO of Terns Pharmaceuticals ($TERN), made one open market purchase of shares in the last year, totaling $90,230, with the most recent on June 25, 2025. This ranks 2,492nd among 4,983 insiders, well below the average buy of 1.5 million across 3.3 transactions. She conducted six open market sales totaling 5.8 million dollars, most recently on February 17, 2026, ranking 1,726th among 11,678 insiders, near the average of 6.4 sales but below the 8.6 million average value.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 14583 | $0.00 | 955,534.0000 | 91,701,529 | 1.50% | 0.02% |
| March 16, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 14583 | $4.64 | 311,878.0000 | 91,701,529 | 4.91% | 0.02% |
| March 16, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 11813 | $46.57 | 300,065.0000 | 91,701,529 | 3.79% | 0.01% |
| March 16, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 2770 | $47.30 | 297,295.0000 | 91,701,529 | 0.92% | 0.00% |
| Feb. 17, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 2341 | $38.07 | 309,537.0000 | 91,701,529 | 0.75% | 0.00% |
| Feb. 17, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 14583 | $4.64 | 311,878.0000 | 91,701,529 | 4.91% | 0.02% |
| Feb. 17, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 4083 | $39.80 | 297,295.0000 | 91,701,529 | 1.35% | 0.00% |
| Feb. 17, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 8159 | $39.22 | 301,378.0000 | 91,701,529 | 2.64% | 0.01% |
| Feb. 17, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 14583 | $0.00 | 970,117.0000 | 91,701,529 | 1.48% | 0.02% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 27083 | $4.64 | 324,378.0000 | 91,701,529 | 9.11% | 0.03% |
| Jan. 14, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | A | Common Stock | 150000 | $0.00 | 297,295.0000 | 91,701,529 | 101.84% | 0.16% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 27083 | $4.64 | 351,461.0000 | 91,701,529 | 8.35% | 0.03% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 14583 | $4.64 | 366,044.0000 | 91,701,529 | 4.15% | 0.02% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 61228 | $37.02 | 304,816.0000 | 91,701,529 | 16.73% | 0.07% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 7521 | $37.53 | 297,295.0000 | 91,701,529 | 2.47% | 0.01% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 14583 | $0.00 | 984,700.0000 | 91,701,529 | 1.46% | 0.02% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 27083 | $0.00 | 999,283.0000 | 91,701,529 | 2.64% | 0.03% |
| Jan. 15, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 27083 | $0.00 | 1,026,366.0000 | 91,701,529 | 2.57% | 0.03% |
| Jan. 14, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 91,701,529 | 9999.99% | 0.33% |
| Jan. 2, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Stock Option (Right to Buy) | 21551 | $0.00 | 1,053,449.0000 | 91,701,529 | 2.00% | 0.02% |
| Jan. 2, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 21551 | $4.64 | 68,634.0000 | 91,701,529 | 45.77% | 0.02% |
| Jan. 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Common Stock | 150000 | $0.00 | 218,634.0000 | 91,701,529 | 218.55% | 0.16% |
| Jan. 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | S | Common Stock | 71339 | $38.10 | 147,295.0000 | 91,701,529 | 32.63% | 0.08% |
| Jan. 5, 2026 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | M | Restricted Stock Unit | 150000 | $0.00 | 0.0000 | 91,701,529 | 100.00% | 0.16% |
| June 25, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | P | Common Stock | 23314 | $3.87 | 47,083.0000 | 79,507,474 | 98.09% | 0.03% |
| May 29, 2025 | Tenaya Therapeutics, Inc. | $TNYA | Burroughs Amy L. | Not found | A | Stock Option (Right to buy) | 107400 | $0.00 | 107,400.0000 | 87,582,646 | 9999.99% | 0.12% |
| Nov. 30, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | P | Common Stock | 510 | $5.11 | 19,609.0000 | 77,819,658 | 2.67% | 0.00% |
| Jan. 30, 2025 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | A | Stock Option (Right to Buy) | 1075000 | $0.00 | 1,075,000.0000 | 79,507,474 | 9999.99% | 1.35% |
| Dec. 5, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | P | Common Stock | 15450 | $7.15 | 19,099.0000 | 77,819,658 | 423.40% | 0.02% |
| Oct. 18, 2024 | Tenaya Therapeutics, Inc. | $TNYA | Burroughs Amy L. | Not found | A | Stock Option (Right to buy) | 34000 | $0.00 | 34,000.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | A | Restricted Stock Unit | 150000 | $0.00 | 150,000.0000 | 71,259,239 | 9999.99% | 0.21% |
| March 1, 2024 | Terns Pharmaceuticals, Inc. | $TERN | Burroughs Amy L. | Chief Executive Officer | A | Stock Option (Right to buy) | 1250000 | $0.00 | 1,250,000.0000 | 71,259,239 | 9999.99% | 1.75% |
| Jan. 3, 2023 | DiaMedica Therapeutics Inc. | $DMAC | Burroughs Amy L. | Director | A | Voting Common Shares, no par value per share | 17156 | $1.53 | 73,288.0000 | 0 | 30.56% | 0.00% |